The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’
George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’View Video
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America
Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin AmericaView Video

Latest Share Chat

Pin to quick picksAKR.L Share News (AKR)

  • There is currently no data for AKR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London close: Footsie finishes below best levels

Fri, 06th Jan 2012 17:17

London closed comfortably below its best levels of the day despite better than expected US jobless data which had some market commentators crying 'foul'.US non-farm payrolls grew by 200,000 during the month of December. The consensus estimate was for a reading of 155,000. Morgan Stanley has suggested, however, that a 'seasonal quirk' distorted today´s non-farm payrolls number by +42,000. Barclays Capital seems to be of a similar opinion, indicating that, "while we characterize this employment report as upbeat and consistent with the underlying acceleration in economic activity in the second half of last year, we suggest that the December data probably overstate the rate of improvement in labor market conditions." Barclays' comments are in reference to the fact that couriers and messengers´ payrolls rose by 42,000 on the month, contributing a large portion of the 90,000 increase in trade and transport payrolls. Gains in couriers and messengers payrolls in December are often reversed in January; for example, the 46,000 increase in December 2010 was reversed in January with 49,000 decline. Despite coming off the top after the US jobs data, the top-share index did at least finish the day - and the week, for that matter - higher than it started it.There was not a lot of corporate news about, and broker commentary seemed to have as much impact on share prices as did news flow.Broker viewsFund managers found themselves out of favour after Credit Suisse issued a research note on the sector. The Swiss bank lowered asset managers Ashmore to "neutral" from "outperform", F&C to "underperform" from "neutral" and Jupiter Fund Management to "neutral" from "outperform".Hedge fund manager Man Group had its target price cut to 175p from 215p by Credit Suisse, and ended the day as the worst performing blue-chip.Mobile phone networks giant Vodafone was on the up after a bullish note from Goldman Sachs, while pubs group Mitchells & Butlers raised a glass to Morgan Stanley, which has recommended buying the shares. Satellite broadcaster BSkyB was brought to earth, however, by Morgan Stanley downgrading the stock to "equal weight" from "overweight". The same broker is keener on another player in the broadcasting sector, ITV, which it has upgraded to "overweight" from "equal weight".Comings and goingsNo-frills airline easyJet was thankful for a mild December, in contrast to the snow-bound final month of 2010. The airline saw a sharp year-on-year increase in the number of passengers carried in December, up 13.1% to 4.14m from 3.66m in December 2010. The load factor eased, however, to 85.6% from 85.8% the year before.Underlying passenger numbers (adjusting for disruption) were 4% higher in December 2011, while underlying load factor was one percentage point up on last year.David McKinney, Chief Operating Officer of Pace, is to leave the set-top box maker after his position disappeared in a management restructuring. Key operations and procurement functions that previously reported to McKinney will now report directly to Mike Pulli, the new Chief Executive Officer who used to be President of Pace Americas. Pulli's old position is to be filled by Tim O'Loughlin, who has been with Pace for more than a decade, many of them as part of Pace's Americas leadership team.Fears that a fourth quarter trading update by recruitment firm Robert Walters might include a profit warning proved unfounded, though the group concedes that conditions in the UK market remain difficult. "Group net fee income for the year ended 31 December 2011 was up 18% [15% on a constant currency basis] to £183.6m (2010: £155.4m) and we expect a satisfactory outcome for 2011 as a whole," revealed Robert Walters, Chief Executive Officer of the company that bears his name.Small caps round-upVimto-maker Nichols issued a bubbly update in which it said 2011 figures will be ahead of market expectations. In January 2012, the company is launching a new range of Weight Watchers branded, low calorie soft drinks into the UK and the Republic of Ireland, which it hopes will add a few pounds to its bottom line.A less welcome profits guidance statement came from dry cleaner Johnson Service Group, which said 2011 profits would be marginally below expectations.Diagnostic screening and testing products developer Akers Biosciences slumped to a 52-week low after warning that 2011 revenues will not come up to scratch.GlobeOp Financial Services, saw its share price soar after confirming recent speculation it is holding discussions with Advent International Corporation and TPG Capital regarding possible offers.FTSE 100 - RisersBurberry Group (BRBY) 1,250.00p +3.91%Petrofac Ltd. (PFC) 1,543.00p +3.35%Amec (AMEC) 963.00p +3.16%WPP (WPP) 690.00p +3.14%Lloyds Banking Group (LLOY) 27.11p +2.88%ITV (ITV) 71.35p +2.74%Weir Group (WEIR) 2,146.00p +2.63%Fresnillo (FRES) 1,661.00p +2.53%Vedanta Resources (VED) 1,006.00p +2.08%Aggreko (AGK) 2,089.00p +1.95%FTSE 100 - FallersMan Group (EMG) 112.70p -8.37%Essar Energy (ESSR) 170.70p -3.12%ICAP (IAP) 319.30p -2.98%Ashmore Group (ASHM) 321.30p -2.90%Admiral Group (ADM) 844.50p -2.48%Land Securities Group (LAND) 621.50p -2.36%Unilever (ULVR) 2,123.00p -2.17%CRH (CRH) 1,216.00p -2.09%Resolution Ltd. (RSL) 250.30p -1.69%British Land Co (BLND) 460.30p -1.67%FTSE 250 - RisersJD Sports Fashion (JD.) 660.00p +11.39%Mitchells & Butlers (MAB) 249.80p +8.70%Salamander Energy (SMDR) 227.50p +5.47%Kenmare Resources (KMR) 47.46p +5.28%Allied Gold Mining (ALD) 157.80p +5.06%Hochschild Mining (HOC) 411.90p +4.97%Premier Oil (PMO) 392.40p +4.67%Centamin (DI) (CEY) 81.80p +4.20%Rightmove (RMV) 1,318.00p +4.19%Carpetright (CPR) 513.00p +4.04%FTSE 250 - FallersInternational Personal Finance (IPF) 160.00p -6.98%Jupiter Fund Management (JUP) 196.00p -5.50%Tullett Prebon (TLPR) 262.30p -3.50%Big Yellow Group (BYG) 255.30p -2.59%Savills (SVS) 336.00p -2.35%Unite Group (UTG) 164.00p -2.15%Derwent London (DLN) 1,535.00p -2.10%F&C Asset Management (FCAM) 60.80p -2.09%SEGRO (SGRO) 200.10p -1.96%Daejan Holdings (DJAN) 2,773.00p -1.32%FTSE TechMARK - RisersPace (PIC) 79.00p +7.12%Microgen (MCGN) 137.50p +5.97%Vectura Group (VEC) 53.25p +4.41%FTSE TechMARK - FallersTorotrak (TRK) 35.00p -3.45%Phoenix IT Group (PNX) 155.00p -2.82%jh
More News
8 Oct 2018 13:10

Akers Biosciences appoints chief executive after settling legal battle

(Sharecast News) - Akers Biosciences appointed Howard Yeaton as chief executive on Monday as the company reached a settlement in its legal dispute with Pulse Health.

Read more
15 Aug 2018 08:04

Akers Biosciences profits hit over antigen difficulties

(Sharecast News) - Akers Biosciences' losses burgeoned as second-quarter revenues were cut in half after softer sales of its flagship Heparin rapid assay products had offset a stronger showing in its breathalyser unit.

Read more
3 Apr 2018 13:45

Akers Biosciences 2017 Revenue Rises But Loss Widens On Higher Costs

LONDON (Alliance News) - Akers Biosciences Inc on Tuesday said revenue grew in 2017, but its loss widened due to increased costs across the business.The AIM-listed firm

Read more
16 Mar 2018 18:11

Akers Biosciences Nets USD49,000 From Warrants Exercise (ALLISS)

LONDON (Alliance News) - Akers Biosciences Inc, a developer of health screening and testing products, said Friday that it has netted USD48,750 from warrants to

Read more
16 Feb 2017 08:44

Akers Biosciences gains US patent for disposable cartridge

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, has been granted a US patent for its wellness disposable markers. The US Patent and Trademark Office has given a patent for its proprietary cartridge for the optical scanning device used in the company's Brea

Read more
10 Jan 2017 12:06

Akers Biosciences to raise $2m in US placing

(ShareCast News) - Rapid diagnostic test manufacturer Akers Biosciences said it plans to issue $2m of new shares plus warrants over another $1m worth of shares. The AIM- and Nasdaq-listed outfit said funds will be used for working capital as well as to accelerate growth in the US and in internationa

Read more
19 Dec 2016 14:52

Akers Biosciences signs three year deal with US hospital group

(ShareCast News) - Rapid health information technology developer Akers Biosciences announced on Friday it has signed a three-year agreement with the Greater New York Hospital Association to introduce its flagship rapid tests for heparin-induced thrombocytopenia across the association's network of ov

Read more
12 Dec 2016 16:03

UK Shareholder Meetings Calendar - Next 7 Days

Read more
1 Dec 2016 12:13

Akers Agrees Deal For First Check To Sell Cholesterol Test In US

Read more
10 Nov 2016 09:46

Akers Biosciences gains European patent for ketone breath device

(ShareCast News) - Akers Biosciences, a developer of rapid health information technologies, gains a European patent for its ketone acid breath device. The European Patent Office has issued a patent covering the company's breath ketone detector, a breath device to monitor ketone levels, which follows

Read more
19 Aug 2016 12:18

Akers Biosciences, ChubeWorkx settle lengthy legal dispute

(ShareCast News) - Akers Biosciences has reached a settlement agreement with former distributor ChubeWorkx Guernsey Ltd, allowing it to recover $1.25m in product and cash and end a lengthy legal dispute between the pair. ChubeWorkx would recover what it was owed from a promissory note by taking deli

Read more
18 Aug 2016 07:22

Akers Says Test Results "Highly Successful" For BreathScan OxiChek

Read more
30 Jun 2016 08:56

Akers Says Rapid Chlamydia Test Trial "Highly Successful"

Read more
27 Jun 2016 08:16

Akers Biosciences Signs First Distribution Deal For BreathScan OxiChek

Read more
26 May 2016 16:27

DIRECTOR DEALINGS: Akers Biosciences Chief Executive Buys First Shares

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.